Shattuck Labs Announces Drug Discovery Collaboration With Ono Pharmaceutical, For Bifunctional Fusion Proteins Targeting Certain Autoimmune And Inflammatory Disease Pathways, Shattuck To Receive Upfront And Be Eligible For Milestone Payments Of Upto $227M
Shattuck Labs宣佈與小野製藥合作開發靶向某些自身免疫和炎症性疾病途徑的雙功能融合蛋白,Shattuck將獲得預付款,並有資格獲得高達2.27億美元的里程碑式付款